218 related articles for article (PubMed ID: 26246476)
1. Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.
Zhang G; Cheng Y; Chen G; Tang Y; Ardekani G; Rotte A; Martinka M; McElwee K; Xu X; Wang Q; Zhou Y
Oncotarget; 2015 Sep; 6(26):23026-35. PubMed ID: 26246476
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific prognostic biomarkers in melanoma.
Cheng Y; Lu J; Chen G; Ardekani GS; Rotte A; Martinka M; Xu X; McElwee KJ; Zhang G; Zhou Y
Oncotarget; 2015 Feb; 6(6):4180-9. PubMed ID: 25784655
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.
Tang Y; Cheng Y; Martinka M; Ong CJ; Li G
Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172
[TBL] [Abstract][Full Text] [Related]
5. The role of the metastasis suppressor gene KAI1 in melanoma angiogenesis.
Tang Y; Bhandaru M; Cheng Y; Lu J; Li G; Ong CJ
Pigment Cell Melanoma Res; 2015 Nov; 28(6):696-706. PubMed ID: 26199094
[TBL] [Abstract][Full Text] [Related]
6. Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females.
Singh R; Bhatt ML; Singh SP; Kumar V; Goel MM; Mishra DP; Srivastava K; Kumar R
Asian Pac J Cancer Prev; 2016; 17(7):3431-6. PubMed ID: 27509988
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.
Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G
Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020
[TBL] [Abstract][Full Text] [Related]
9. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R
Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143
[TBL] [Abstract][Full Text] [Related]
10. Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.
Chen G; Cheng Y; Tang Y; Martinka M; Li G
J Invest Dermatol; 2012 Nov; 132(11):2632-41. PubMed ID: 22673729
[TBL] [Abstract][Full Text] [Related]
11. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
[TBL] [Abstract][Full Text] [Related]
12. [Role of KAI1 gene expression and loss of heterozygosity of KAI1 in metastatic potential and prognosis of pancreatic cancer].
Fan LX; Shen L; Li JY; Pan KF; Dong B; Zhang Y
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):42-6. PubMed ID: 19489224
[TBL] [Abstract][Full Text] [Related]
13. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
Li Q; Murphy M; Ross J; Sheehan C; Carlson JA
J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322
[TBL] [Abstract][Full Text] [Related]
14. A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas.
Chen R; Zhang G; Zhou Y; Li N; Lin J
Diagn Pathol; 2014 Aug; 9():155. PubMed ID: 25116415
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
16. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
[TBL] [Abstract][Full Text] [Related]
17. Association of galectin-3 expression with melanoma progression and prognosis.
Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
[TBL] [Abstract][Full Text] [Related]
18. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
19. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
